CASP3 and neoplasm: The results of anti-tumor activity studies showed that the combination therapy group induced apoptosis by up-regulating the expression of Caspase-3/PARP protein, and had a good therapeutic effect on patient-derived hepatocellular carcinoma xenografts (PDXHCC) after irradiation.